DCF — AVERA WESKOTA MEMORIAL MEDICAL CENTE
Enterprise Value: $6.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$6.3M
Enterprise Value
$1.7M
PV of Cash Flows
$4.6M
PV of Terminal Value
$7.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $5.6M | $0.8M | 13.0% | $0.4M | $0.3M |
| Year 2 | $5.8M | $0.8M | 14.0% | $0.4M | $0.3M |
| Year 3 | $5.9M | $0.9M | 15.0% | $0.5M | $0.4M |
| Year 4 | $6.1M | $1.0M | 16.0% | $0.5M | $0.4M |
| Year 5 | $6.3M | $1.0M | 16.0% | $0.5M | $0.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $6.3M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$5.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.12999496849846512
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5